Furthermore, we have shown that system xC− activity is also associated with CIBP, where a known inhibitor of this antiporter, SSZ, reduces pain behaviours linked to the growth of MDA-MB-231 tumours in the distal femur46. This evidence concerns the gene CIB1 and neoplasm.